Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Effects of F-1394 on cholesterol esterification/secretion in cultured human intestinal cells

Dec. 15, 1997

Raloxifene clinical data supports therapeutic utility of novel SERM

Dec. 15, 1997

Cangene to evaluate Leucotropin in phase III

Dec. 15, 1997

Discovery of novel, orally active ACAT inhibitor, FR-186054, reported by Fujisawa

Dec. 15, 1997

Novel hypoglycemic thiazolidinedione derivative presented by Kyorin

Dec. 15, 1997

TheraTech and P&G to codevelop hormone replacement patches

Dec. 12, 1997

Site-directed, sustained-release delivery system for estradiol in development at Fujisawa

Dec. 12, 1997

Kyowa Hakko prepares new, water-soluble indole for osteoporosis

Dec. 12, 1997

Tokyo Tanabe moves new oxytocin antagonist to clinic

Dec. 12, 1997

FDA approves SERM for preventing postmenopausal osteoporosis

Dec. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.